how is retatrutide different from ozempic vs Megan Adelman (Elavsky), PharmD, BCPS, BCGP, CDCES posted on LinkedIn I plateaued on Ozempic —

Endothelial dysfunction in diabetes mellitus

doi: 10.2337/db16-0512 176 AlcendorRRGaoSZhaiPZablockiDHolleEYuXet al

SURMOUNT-2, in participants with type 2 diabetes, showed 12.8% and 14.7% weight loss at 10mg and 15mg respectively

First Mover States in GLP-1 Coverage Colorado No state garnered more attention than Colorado

4 Clinical evidence in T2DM management A wide range of clinical trials and research have been performed to assess the effectiveness, safety, and tolerability of short-acting against long-acting GLP-1 analogues in the treatment and management of T2DM and obesity

Theres also the issue of electrolyte imbalance